Guided Therapeutics (GTHP) Capital Expenditures (2011 - 2022)
Guided Therapeutics recorded quarterly Capital Expenditures of $3000.0 in Q4 2022, up 200.0% quarter-over-quarter from -$3000.0 in Q3 2022, and down 25.0% year-over-year from $4000.0 in Q4 2021.
Guided Therapeutics' Capital Expenditures history runs 8 years deep, the most recent figure standing at $3000.0 for Q4 2022.
- In Q4 2022, Capital Expenditures fell 25.0% year-over-year to $3000.0; the TTM figure through Sep 2023 stood at $3000.0 (down 90.62% YoY), while the FY2025 annual figure was $2000.0, changed N/A from the prior year.
- Capital Expenditures came in at $3000.0 for Q4 2022 at Guided Therapeutics, up from -$3000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $17000.0 in Q2 2022 to a low of -$3000.0 in Q3 2022.
- A 3-year average of $5111.1 and a median of $4000.0 in 2021 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 1300.0% in 2022 and fell as far as 160.0% in 2022.
- Guided Therapeutics' Capital Expenditures stood at $1000.0 in 2020, then soared by 300.0% to $4000.0 in 2021, then fell by 25.0% to $3000.0 in 2022.
- According to Business Quant data, Capital Expenditures over the past three periods registered $3000.0, -$3000.0, and $17000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Dec 31, 2015 | 6,000.00 |
| Dec 31, 2015 | 6,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2015 | 2,000.00 |
| Sep 30, 2014 | 25,000.00 |
| Sep 30, 2014 | 25,000.00 |
| Jun 30, 2014 | 115,000.00 |
| Jun 30, 2014 | 115,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | -218,000.00 |
| Dec 31, 2013 | -218,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 101,000.00 |
| Mar 31, 2013 | 101,000.00 |
| Dec 31, 2012 | -1.05 Mn |
| Dec 31, 2012 | -1.05 Mn |
| Sep 30, 2012 | 145,000.00 |
| Sep 30, 2012 | 145,000.00 |
| Jun 30, 2012 | 481,000.00 |
| Jun 30, 2012 | 481,000.00 |
| Mar 31, 2012 | -130,000.00 |
| Mar 31, 2012 | -130,000.00 |
| Dec 31, 2011 | -180,000.00 |
| Dec 31, 2011 | -180,000.00 |
| Sep 30, 2011 | -229,000.00 |
| Sep 30, 2011 | -229,000.00 |
| Jun 30, 2011 | -19,000.00 |
| Jun 30, 2011 | -19,000.00 |
| Mar 31, 2011 | -16,000.00 |
| Mar 31, 2011 | -16,000.00 |